Nicolas Sailliet

Mr. Nicolas Sailliet

UMR 1064, Centre de Recherche en Transplantation et Immunologie, Inserm, CHU Nantes, Université de Nantes, ITUN, F-44000 Nantes, France
+2
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
QLQi Liu
Qi Liu
SLShiying Li
Shiying Li
ADAmandine Dupuy
Amandine Dupuy
HMHoa le Mai
Hoa le Mai
NSNicolas Sailliet
Nicolas Sailliet
Sophie BrouardSophie Brouard
Sophie Brouard
Exosomes are nano-sized vesicles secreted by most cells that contain a variety of biological molecules, such as lipids, proteins and nucleic acids. They have been recognized as important mediators for long-distance cell-to-cell communication and are involved in a variety of biological processes. Exosomes have unique advantages, positioning them as highly effective drug delivery tools and providing a distinct means of delivering various therapeutic agents to target cells. In addition, as a new clinical diagnostic biomarker, exosomes play an important role in many aspects of human health and disease, including endocrinology, inflammation, cancer, and cardiovascular disease. In this review, we summarize the development of exosome-based drug delivery tools and the validation of novel biomarkers, and illustrate the role of exosomes as therapeutic targets in the prevention and treatment of various diseases.

7 November 2024 in European Journal of Immunology
Verified
Journal Article
Open access
FBFrançois Brinas
François Brinas
NSNicolas Sailliet
Nicolas Sailliet
GTGaëlle Tilly
Gaëlle Tilly
LDLaurence Delbos
Laurence Delbos
CKClarisse Kerleau
Clarisse Kerleau
RDRichard Danger
Richard Danger
The use of immunosuppressive treatment is required to prevent rejection events, even a long time after kidney transplantation despite rare recipients achieving long‐term graft stability without the need for immunosuppressive treatment, called operationally tolerant patients (TOLs). We comprehensively investigate the immune system of long‐term IS recipients (LTTs) and TOLs to highlight their shared and unique immune features. Blood immune cell phenotyping was performed by spectral cytometry. Samples from 34 individuals were analyzed, including 6 LTTs, 8 TOLs, 10 stable patients at 1 year posttransplantation (STAs), and 10 healthy volunteers. B cells differed between LTTs and TOLs with a decreased total B‐cell frequency and the acquisition of a memory phenotype in LTTs whereas a naive phenotype is maintained in TOLs. The frequencies of IgD−CD27− B cells and CD11c+ memory B cells are increased in LTTs, with an exhausted phenotype, evoked by a significant decrease in CD25 expression. These CD11c+ B cells display an exhausted phenotype similar to those found in several chronic immune diseases in which they have been shown to participate in their pathophysiology, suggesting active chronic inflammation in LTTs. Altogether, these data indicate that precautions should be taken to minimize IS use.

27 January 2026 in Kidney360
Verified
Journal Article
Open access
Laureline BerthelotLaureline Berthelot
Laureline Berthelot
Nicolas DegauqueNicolas Degauque
Nicolas Degauque
LCLaura Cappelier
Laura Cappelier
NSNicolas Sailliet
Nicolas Sailliet
CMCamille Mathé
Camille Mathé
Sophie BrouardSophie Brouard
Sophie Brouard
Key Points: Tolerant patients of kidney graft exhibit higher IgA production than other kidney transplanted patients without modification for IgG. IgA-expressing B cells from tolerant patients expressed granzyme B and exert regulatory functions through granzyme B production. Background: Tolerant kidney transplant recipients without immunosuppression have a high frequency of circulating granzyme B (GZMB)–expressing regulatory B cells (Breg). Because the precursors of these Bregs remain unknown and IgA-secreting B cells have been shown to have regulatory properties in different situations, we investigated the association between IgA- and GZMB-expressing B cells in a case-control study. Methods: Forty-five healthy volunteers and 31 kidney transplant recipients with either stable graft function under immunosuppression ( n =10), antibody-mediated rejection ( n =7), or tolerant patients (TOL; n =14) were included. Serum immunoglobulin concentrations as glycosylation were measured by ELISA; forms of IgA were examined by Western blot. Bregs were analyzed by single-cell RNA sequencing and multiparameter spectral flow cytometry. Their function was assessed in cocultured with T cells. Results: Serum IgA concentration was elevated in TOL compared with other transplanted patients, especially the noninflammatory IgA1 subclass, without changes in IgA size or glycosylation. Single-cell transcriptomic analysis revealed higher IgA gene expression in GZMB expressing B cells and conversely higher GZMB gene expression in IgA-expressing B cells. Phenotyping analysis by spectral multiparameter flow cytometry showed that IgA+ B cells were memory B cells, and that IgA+ B cells from TOL tended to express more GZMB compared with antibody-mediated rejection patients. In functional assays, IgA+ B cells exhibited high regulatory functions that were partially prevented by the presence of GZMB inhibitor. Conclusions: These data show a strong association between IgA+ and GZMB+ Bregs, particularly in tolerant kidney transplant recipients with higher GZMB and IgA expression and greater suppressive properties. Clinical Trial registry name and registration number: NCT02900040.

7 April 2026
Verified
Thesis
Closed access
NSNicolas Sailliet
Nicolas Sailliet
Les lymphocytes B régulateurs sont une population hautement hétérogène qui a montré son efficacité à supprimer les mécanismes effecteurs du système immunitaire. Dans la première partie de cette thèse nous allons étudier la population de lymphocytes B régulateurs mis en évidence chez les patients transplantés rénaux opérationnellement tolérants, les lymphocytes B régulateurs exprimant le granzyme B en comparant le transcriptome, le phénotype et la fonction de lymphocytes B après induction de granzyme B et d’une fonction régulatrice à des lymphocytes B non régulateurs, n’exprimant pas le granzyme B. Nous avons pu mettre en évidence le rôle de la lymphotoxine alpha dans la biologie de ces cellules, où l’inhibition de cette cytokine par le Pateclizumab diminue l’expression de granzyme B et réduit leur fonction suppressive. L’inflammation de type 2 et l’expression de cytokines hautement inflammatoires et pruritiques tels que l’IL-13 et l’IL-33 sont hautement pathogéniques dans la dermatite atopique et les traitements anti-JAK ciblant ces voies cytokiniques de façon non spécifique ont montré leur efficacité chez des patients ne répondant pas aux traitements conventionnels. Dans la seconde partie de cette thèse, nous évoquerons la caractérisation fonctionnelle et phénotypique des cellules immunitaires circulantes de patients atteints de dermatite modérée à sévère, et le développement de tests immunologiques pour caractériser l’impact des inhibiteurs de JAK dans ce contexte pathologique.

9 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SGSteve Genebrier
Steve Genebrier
NSNicolas Sailliet
Nicolas Sailliet
SSSamuel Serra-Trinca
Samuel Serra-Trinca
HMHoa Le Mai
Hoa Le Mai
ADAmandine Dupuy
Amandine Dupuy
Michel CognéMichel Cogné
Michel Cogné
Regulatory B cells (Bregs) play a pivotal role in various dysimmune conditions. We have previously demonstrated that granzyme B-expressing (GZMB⁺) B cells are more numerous in patients with graft tolerance following kidney transplantation and that these cells display regulatory properties through GZMB. However, their ontogeny remains poorly understood. To address this gap, we analyzed the B cell receptor repertoire of GZMB⁺ Bregs and GZMB⁻ B cells sorted from healthy donors and drug-free tolerant kidney-graft recipients. This revealed that both subsets exhibited similar repertoire features in terms of diversity, V/J gene usage, CDR3 profile and somatic hypermutation pattern, suggesting a common origin and recent divergence. Furthermore, there was limited overlap between GZMB⁺ and GZMB⁻ clonotypes within individual donors. Taken together, these findings suggest that GZMB⁺ Bregs likely arise from the conventional mature B cell pool and represent a differentiation state shaped by environmental cues rather than constituting a distinct clonal lineage.